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Abstract 11 
There is a lack of data on the occurrence of pharmaceuticals in estuaries worldwide, with 12 
little understanding of their temporal and spatial variations globally. Ibuprofen, paracetamol, 13 
diclofenac, trimethoprim and citalopram were measured in twelve estuaries in the UK.  14 
Initially, these compounds were monitored in the Humber Estuary, where samples were 15 
taken every two months over a twelve month period in order to assess their spatial and 16 
temporal variations. Ibuprofen was found at some of the highest concentrations ever 17 
measured in an estuary globally (18 ± 6297ng l-1), with paracetamol also measured at 18 
relatively high concentrations (4 ± 917 ng l-1) in comparison to the other compounds. In 19 
terms of spatial distribution, a pattern was observed where the highest concentrations were 20 
found at a site at which wastewater is discharged, whilst compound concentrations were 21 
often lower upstream and downstream of this site. The downstream profile of 22 
pharmaceuticals differed temporally with concentrations highest downstream when input 23 
from wastewater effluent was highest. Eleven further estuaries were sampled around the UK 24 
in order to put the occurrence of pharmaceuticals in the Humber Estuary into a wider 25 
context. Pharmaceutical concentrations in the other estuaries sampled were less than 210 26 
ng l-1  but, again, ibuprofen and paracetamol were found at concentrations higher than other 27 
compounds, whereas diclofenac and citalopram were absent in many estuaries. The 28 
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Humber, which is the receiving environment for the sewage effluent of approximately 20% 29 
(13.6 million people) of the population of England, was observed to have the highest overall 30 
concentration of pharmaceuticals in contrast to the other estuaries sampled, thereby 31 
representing a worst case scenario for pharmaceutical pollution.  32 
Keywords: Pharmaceuticals; Emerging Contaminants; Estuary; Occurrence; Temporal 33 
Distribution; Spatial Distribution 34 
1. Introduction 35 
Despite the extensive and long-term use of pharmaceuticals, it has only been in the past few 36 
decades that interest in pharmaceutical pollution has gained popularity and now hundreds of 37 
pharmaceuticals have been detected in the aquatic environment (Hughes et al. 2013; Gaw 38 
et al. 2014). Their presence is sustained through continuous input from wastewater 39 
treatment plants (WWTPs), as well as from improper disposal, agriculture and aquaculture 40 
(Godoy et al. 2015). Pharmaceuticals are designed to be biologically active, often at low 41 
levels, and their presence in surface water has led to concern over their potential biological 42 
effect (Santos et al. 2010). Many pharmaceuticals (e.g. diclofenac and fluoxetine) have been 43 
found to illicit a negative response on biota in laboratory exposures at concentrations similar 44 
to those found in the aquatic environment (Eades and Waring 2010; Franzellitti et al. 2013; 45 
Minguez et al. 2016).  46 
The fate of pharmaceuticals is best understood in the freshwater environment, with input, 47 
environmental conditions, biological degradation and sediment-related processes playing a 48 
prominent role in their spatial and temporal distribution (Li 2014). Pharmaceuticals often 49 
show a decline in concentration downstream from input sources as the result of dilution, 50 
degradation and partitioning to sediment (Kunkel and Radke 2012). However, due to the 51 
prevalence of WWTPs, this leads to the continuous input of pharmaceuticals into the 52 
environment. As a result, these processes are not enough to sufficiently remove compounds 53 
leading to their high detection in the aquatic environment and, potentially, transportation into 54 
estuaries and coastal waters (Ebele et al. 2017).  55 
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Estuaries are receiving waters, often for many rivers, acting as a confluence for 56 
contaminants and therefore increasing the potential risk of pharmaceutical pollution in these 57 
environments (Ridgway and Shimmield 2002). Estuaries are ecologically important to 58 
ecosystem services, providing habitat for many species and acting as an area for recreation 59 
and transport (Ridgway and Shimmield 2002). Despite this, few studies have measured the 60 
occurrence of pharmaceuticals in estuaries, and those that do exist typically lack the 61 
resolution to determine spatial and temporal patterns (Table 1). Studies which have 62 
investigated the spatial and temporal patterns of pharmaceuticals are often locally focused, 63 
monitoring only one estuary (for example Tamtam et al., 2012; Hedgespeth et al. 2012; 64 
Cantwell et al. 2017), and it is important to determine if any patterns seen are relevant at a 65 
wider scale and represent a risk to the environment. 66 
This study aimed to further contribute to the overall picture of pharmaceutical contamination 67 
in estuaries. Five target compounds, ibuprofen, paracetamol, diclofenac, trimethoprim and 68 
citalopram, were chosen for the present study, based on their prevalent usage and predicted 69 
risk to the aquatic environment (National Health Service 2017; Roos et al. 2012). To the 70 
authors¶ knowledge, citalopram has not previously been monitored in the estuarine 71 
environment (Table 1). Moreover, monitoring of the aforementioned compounds is limited, 72 
with some of these measurements dating back almost fifteen years. The target compounds 73 
were measured every other month over a twelve month period at various sites in the Humber 74 
Estuary to determine their spatial and temporal occurrence. In addition, eleven further 75 
estuaries, located in other parts of the UK, were selected in order to determine whether 76 
concentrations observed in the Humber were representative of other estuaries.  77 
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Table 1: Maximum concentrations of ibuprofen, paracetamol, diclofenac and trimethoprim detected in 78 
estuaries globally (ng l-1). Citalopram has not previously been monitored in any estuaries.  79 
Region Estuary 
Ib
up
ro
fe
n
 
Pa
ra
ce
ta
m
o
l 
D
ic
lo
fe
n
ac
 
Tr
im
et
ho
pr
im
 Reference 
Asia Jiulong, China 21 13 11  Sun et al. (2016) 
Hailing Bay, China    37 Chen et al. (2015) 
Qinzhou Bay, China   7  Cui et al. (2019) 
Yangtze, China   <MDL  Yang et al. (2011) 
Yangtze, China    330 Zhang et al. (2012) 
Yangtze, China  <MDL   Zhao et al. (2015) 
Europe Seine, France    45 Tamtam et al. (2008) 
Elbe, Germany 1  1  Weigel et al. (2002) 
Arade, Portugal 28 88 31  Gonzalez-Rey et al. (2015) 
Douro, Portugal    16 Madureira et al. (2010) 
Tejo, Portugal <MDL 11 52 8 Reis-Santos et al. (2016) 
Bilbao, Spain  440 650 2046 Mijangos et al. (2018) 
Plentzia, Spain  49 22 6 Mijangos et al. (2018) 
Urdaibai, Spain  321 35 3 Mijangos et al. (2018) 
Belfast Lough, UK 376 <MDL <MDL 32 Thomas and Hilton (2004) 
Mersey, UK 386 <MDL 195 569 Thomas and Hilton (2004) 
Tees, UK 88 <MDL 191 17 Thomas and Hilton (2004) 
Thames, UK 928 <MDL 125 <MDL Thomas and Hilton (2004) 
Thames, UK    19 Munro et al. (2019) 
Tyne, UK 755  90 46 Thomas and Hilton (2004) 
North 
America 
Charleston Harbour, USA 8 28   Hedgespeth et al. (2012) 
Jamaica Bay, USA 38 156  125 Benotti and Brownawell 
(2007) 
Narragansett Bay, USA  60  18 Cantwell et al. (2017) 
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New York Bay, USA  162  14 Cantwell et al. (2018) 
San Francisco, USA    4 Klosterhaus et al. (2013) 
Oceania Sydney, Australia  31   Birch et al. (2015) 
 80 
2. Methods 81 
2.1 Study Area 82 
The Humber Estuary is a macrotidal estuary located in Yorkshire, on the East Coast of 83 
England, UK (Figure 1). It is 303 km2, has an average depth of 6.5 m and is the confluence 84 
of the Rivers Ouse, Trent and Hull which pass through some of the largest urban areas in 85 
the UK, thus it is the receiving water for approximately 20% of UK effluent (European 86 
Environment Agency, 2019; Table 2). Samples were collected from nine sites along a 65 km 87 
stretch on the North side of the estuary (Figure 1). Two of these were located in the River 88 
Ouse; A1 was the furthest upstream and A2 was located less that 1km upstream from the 89 
confluence with the Humber Estuary. The furthest site upstream in the Humber Estuary (R1) 90 
was the receiving site for effluent from Melton WWTP, which serves a population equivalent 91 
(PE) of 12,255 (European Environment Agency, 2017). Three sites (R2-R4) were positioned 92 
every 2 km downstream from R1. Three final sites (A3-A5) were located 20km from R1 in the 93 
lower estuary and 15 km from the mouth. Further information on site location can be found in 94 
supplementary material S1. The Humber Estuary is an important site for conservation and 95 
has been designated as a Special Protection Area (SPA), also containing a Special Area of 96 
Conservation (SAC). It is also a vital habitat for many species of international importance, 97 
providing habitat for 4.1% of the red knot (Calidris canutus) and 5.7% of the common 98 
redshank (Tringa tetanus) international populations, and as a result has also been 99 
designated as a RAMSAR site (Buck et al. 1997) 100 
Samples were also collected from eleven further estuaries which encompassed a range of 101 
estuary types, tidal ranges and sizes (Table 2). The total PE was calculated for the WWTPs 102 
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in the catchment area of each estuary (Table 2); further information on the proximity of 103 
WWTPs to the sampling sites in each estuary can be found in supplementary material S2.  104 
Many of these estuaries have been designated as SACs, SPAs and RAMSAR sites as the 105 
result of the sensitive and important species resident to them. 106 
Table 2: Information on the type and size of estuaries sampled (Davidson et al.1991). 107 
Information on the number of WWTPs and the population equivalent served in 2014 was 108 
calculated from an interactive wastewater treatment map (European Environment Agency 109 
2019).  110 
Estuary Type Estuary 
Area (km2) 
Tidal 
Type 
Number of 
WWTPs in 
Catchment 
Total PE 
(000s) 
Cromarty Complex 92.3 Mesotidal 3 15.6 
Forth Complex 84.0 Macrotidal 33 1 613.3 
Humber Coastal Plain 303.6 Macrotidal 304 13 674.7 
Mersey Coastal Plain 89.1 Macrotidal 30 3 689.7 
Portsmouth Ria 15.9 Macrotidal 2 383 
Severn Coastal Plain 556.8 Macrotidal 171 6 724.4 
Solway Complex 420.6 Macrotidal 20 314.9 
Tay Complex 121.3 Mesotidal 12 167.6 
Tees Coastal Plain 13.5 Macrotidal 9 844.9 
Thames Coastal Plain 46.5 Macrotidal 198 16 510.5 
Tyne Complex  7.9 Macrotidal 6 1 092.8 
Ythan Barbuilt 2.8 Mesotidal 1 11.2 
 111 
2.2 Sampling  112 
2.2.1 Seasonal Monitoring 113 
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Sampling was carried out in the Humber Estuary, UK, every two months from October 2016 114 
to August 2017 at sites R1-R4 (Figure 1).  Samples were also collected from four additional 115 
sites (A1-A2 and A4-A5) in October, February and June, and a further site (A3) in February 116 
and June (Figure 1). Sampling was carried out during a high neap tide (± 3 hours) to 117 
minimise differences in diurnal concentrations as the result of tides (Lara-Martin et al. 2014).  118 
At each site, 3 x 1 L of surface seawater were collected in amber glass bottles and 119 
temperature, pH and dissolved oxygen determined using a HACH meter and salinity (0 ± 27 120 
ppt) measured with a refractometer (supplementary material S1).  Water samples were kept 121 
on ice or in the fridge at 4 °C and extracted within 48 hours for analysis of  pharmaceuticals.   122 
2.2.2 UK Wide Monitoring 123 
Sampling was carried out in August and September 2017 during high tides (± 3 hours) in 124 
eleven additional UK estuaries in order to provide a wider context for the concentrations of 125 
pharmaceuticals seen in the Humber Estuary (Figure 1). Within each estuary, sites were 126 
chosen in the upper, middle and lower parts of the estuary and 1 L of water was collected at 127 
each of these in amber glass bottles. Temperature, pH, dissolved oxygen and salinity (0-34 128 
ppt) were determined as above and samples stored and extracted in the same manner 129 
(supplementary material S2). 130 
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 131 
Figure 1 Map of field sites for seasonal and UK wide monitoring of selected 132 
pharmaceuticals. The sites in the box (R1-R4) indicate those which were sampled every two 133 
months whilst A1-A2 and A3-A5 were sampled every four months.  134 
 135 
2.3 Chemical Analysis 136 
2.3.1 Study Compounds  137 
Five study compounds, ibuprofen, paracetamol, diclofenac, trimethoprim and citalopram, 138 
were chosen for monitoring (Table 3) and standards of dLFORIHQDF VRGLXP 139 
DFHWDPLQRSKHQFLWDORSUDPLEXSURIHQDQGWULPHWKRSULPZHUH140 
supplied by Sigma-Aldrich Ltd. (Dorset, UK).   141 
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Table 3: Physico-chemical characteristics of the study compounds. Physico-chemical data obtained 142 
from Alygizakis et al. (2016), Bayen et al. (2013)  and Kasprzyk-Hordern et al. (2007). Prescription 143 
data obtained from National Health Service (2019); supplementary material S3.  144 
Compound Therapeutic Use Prescriptions  
(kg year-1) 
Water 
Solubility 
(mg l-1) 
LogKOW Molecular 
Weight 
pKa 
Ibuprofen Nonsteroidal anti-
inflammatory drug 
(NSAID) 
 
82,756 41.05 3.97 206.29 9 
Paracetamol Painkiller 
 
2,169,244 22.7 0.9 151.16 9.9 
Diclofenac NSAID 
 
5459 4.52 4.51 296.15 4.2 
Trimethoprim Antibiotic 
 
8444 171.1 1.4 290.32 7.1 
Citalopram Antidepressant  9204 4.02 3.74 324.39 9.4 
 145 
2.3.2 Solid Phase Extraction 146 
A composite sample was made by combining the 3 x 1L surface water samples collected 147 
from each site during seasonal monitoring, or from each of the estuaries during the UK-wide 148 
survey, by adding them together in a 5 L beaker and stirring vigorously for two minutes. A 149 
500 mL sub-sample was filtered through a 0.45 µm cellulose filter (Scientific Laboratory 150 
Supplies, Hessle, UK) under vacuum. Solid phase extraction was performed on the filtered 151 
water samples using Oasis HLB cartridges (Waters Corporation, Massachusetts, USA), 152 
which were conditioned with 5 mL 100% methanol followed by 5 mL deionised water at a 153 
rate of 1 mL min-1. The sample was loaded on to the cartridge at a rate of 10 mL min-1, 154 
during which care was taken not to let the sorbent material dry out. The cartridges were then 155 
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rinsed with 5 mL deionised water and the sorbent was dried under vacuum for 15 minutes to 156 
remove excess water prior to elution. Elution was performed with 2 x 5 mL 0.1% trifluroacetic 157 
acid in methanol. The eluent was evaporated to dryness using a rotary evaporator (40ºC, 158 
speed 7) and reconstituted with methanol: water (10:90).  159 
SPE recovery was evaluated by spiking known concentrations (100, 200, and 1000 ng l-1) of 160 
all study compounds into three replicates each of artificial seawater made up to 20 ppt in 161 
deionised water (supplementary material S4). The mean recovery across all concentrations 162 
was used to correct the measured environmental concentrations (Table 4). 163 
Table 4: Mean method detection limits (± standard deviation), mean method quantification levels (± 164 
standard deviation) and mean recovery (± standard deviation) of target compounds.  165 
Compound MDL (ng l-1) MQL (ng l-1) Recovery (%) 
Citalopram 0.34 (0.25) 1.18 (0.85) 43 (5.5) 
Diclofenac 1.77 (1.35) 5.91 (4.49) 20 (11.0) 
Ibuprofen 1.45 (0.41) 4.83 (1.38) 73 (34.0) 
Paracetamol 3.28 (1.82) 10.93 (6.07) 86 (34.1) 
Trimethoprim 0.07 (0.04) 0.24 (0.12) 63 (10.6) 
 166 
2.3.3 UltraperformanceTM-ESI-(QqLIT) MS/MS analysis  167 
Analysis was carried out according to Gros et al. (2012). Briefly, chromatographic 168 
separations were performed with a Waters Acquity Ultra-Performance liquid chromatograph 169 
system equipped with two binary pump systems (Milford, Massachusetts, USA) and coupled 170 
to a 5500 QTRAP hybrid quadrupole-linear ion trap mass spectrometer with a turbo ion 171 
spray source (Applied Biosystems, Foster Systems, Foster City, CA, USA). Citalopram and 172 
trimethoprim were analysed under positive electrospray ionisation (PI) using an Acquity HSS 173 
T3 column (50 mm x 2.1 mm, 1.8µm particle size) and ibuprofen, paracetamol and diclofenac 174 
were analysed under negative ion (NI) electrospray using an Acquity BEH C18 column (5 mm 175 
x 2.1 mm, 1.7 µm particle size), both from Waters Corporation. 176 
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All data acquisition was performed in Analyst 2.1 software.  Quantification of analytes was 177 
performed by selective reaction monitoring (SRM), monitoring two transitions for each 178 
compound as described in Gros et al. (2012).  Method detection limits (MDL) and 179 
quantification levels (MQL) were determined for each of the compounds based on a signal-180 
to-noise ratio of 3 and 10 respectively (Table 4).  181 
 182 
2.4 Statistical Analysis 183 
Statistical analysis was performed in R 3.3.1. In order to determine if there was a difference 184 
in the occurrence of pharmaceuticals between sampling months, concentrations from R1-4 185 
were grouped together, as these sites were sampled during all of the sampling periods. A 186 
)ULHGPDQ¶V 7HVW IROORZHG E\ D 1HPHQ\L SRVW-hoc test were conducted using the PMCMR 187 
package (Pohlert 2014). All data is presented in graphs created by the ggplot2 package 188 
(Wickham 2016).  189 
 190 
3. Results 191 
3.1 Humber Estuary 192 
Pharmaceuticals were frequently detected (58 - 97% of samples for individual study 193 
compounds) in the Humber Estuary (Table 5) and concentrations followed the order of 194 
ibuprofen>paracetamol>diclofenac>trimethoprim>citalopram. Whilst mean concentrations 195 
were in the order of 100 ng l-1 or below, maximum concentrations were approximately five to 196 
ten times higher (Table 5; supplementary material S5). Maximum levels of ibuprofen and 197 
paracetamol detected in the Humber are the highest concentrations reported in estuaries to 198 
date (Table 1).  199 
 200 
 12 
 
Table 5: Pharmaceutical concentrations (ng l-1) in the Humber Estuary (n=38) during a 12 month 201 
sampling campaign. Values were corrected based on mean recovery values (Table 3).  Max = 202 
maximum concentration, SD = standard deviation. Detection rate is the amount of samples above the 203 
method quantification limit (MQL).  204 
Compound Detection Rate 
(%) 
Max 
(ng l-1) 
Mean  
(ng l-1) 
SD 
Ibuprofen 97.37 6297.14 665.58 1481.49 
Paracetamol 73.68 916.88 88.65 163.66 
Diclofenac 57.89 250.8 51.44 68.29 
Trimethoprim 92.11 247.02 27.43 54.56 
Citalopram 89.47 42.93 6.39 7.66 
 205 
A general pattern was observed in the occurrence of pharmaceuticals in the Humber with 206 
concentrations peaking at sampling site R1 (Figures 2) and those up (samplings sites A1-207 
A2) and downstream (sampling sites R2-A5) of this site similar to each other. However, this 208 
pattern was not entirely consistent and sometimes concentrations declined downstream (A3-209 
A5). Maximum concentrations were generally seen at sampling site R1 although during 210 
some of the sampling periods they occurred at sites R2-R4. 211 
Of the three months where all sites were sampled February had the highest detection rates 212 
and concentrations of pharmaceuticals at downstream sites (A3-A5), whilst many of the 213 
compounds were absent at these sites in October and June (Figure 2). In contrast, ibuprofen 214 
was an exception to this with concentrations found at these sites during all of the sampling 215 
periods. Citalopram also showed little decline in downstream concentrations in June and 216 
was present at A3-A5 at concentrations similar to or higher than many of the sites further 217 
upstream (Figure 2). There appeared to be a relationship between the concentration of 218 
pharmaceuticals at R1 and those seen at the other sites; typically, a higher concentration at 219 
R1 resulted in a higher presence at sites further downstream (Figure 2).  220 
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Trimethoprim was the only compound to show a statistically significant difference between 221 
VDPSOLQJ PRQWKV )ULHGPDQ¶V 7HVW FKL-squared = 14.71, p < 0.05) with concentrations 222 
significantly higher in winter (December and February; 3.29 ± 166.54 ng l-1) compared to 223 
October and the summer months (June and August; 0 ± 142 ng l-1; Figure 3). Nevertheless, 224 
the difference was almost significant for ibuprofen (p = 0.054) and citalopram (p = 0.051). 225 
For citalopram, February had the highest concentrations (3.74 ± 42.93 ng l-1), whereas 226 
ibuprofen concentrations were higher in April and June (186.37 ± 6297.14 ng l-1; Figures 3) 227 
in comparison to the other sampling periods. All compounds were found at their lowest mean 228 
concentrations in August (Figures 3), with no peaks seen at sampling site R1 (Figure 2).  229 
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Figure 2 Concentrations of target analytes at nine sites in the Humber Estuary. Values were 231 
corrected based on mean recovery values (Table 3). Sites are listed from furthest upstream (A1) to 232 
furthest downstream (A5). R1-R4 were sampled every sampling event whilst the other sites were only 233 
sampled in October, February and June, except for A1 which was not sampled in October.  234 
 235 
Figure 3 Mean bi-monthly concentrations (± one standard deviation) of (A) Ibuprofen (B) Paracetamol 236 
(C) Diclofenac (D) Trimethoprim and (E) Citalopram at the four sites monitored most frequently (R1-237 
R4). Values were corrected based on mean recovery values (Table 3). Letters denote statistically 238 
VLJQLILFDQWGLIIHUHQFH)ULHGPDQ¶V7HVW. 239 
 240 
3.2 UK-wide sampling 241 
Pharmaceuticals were detected in all of the estuaries sampled around the UK but only at 242 
concentrations in the low ng l-1 range, generally lower than those detected in the Humber 243 
Estuary (Figure 4). Relative concentrations were similar to that found in the Humber; 244 
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ibuprofen>paracetamol>diclofenac>citalopram>trimethoprim (supplementary material S6). 245 
Ibuprofen and trimethoprim were present in all of the estuaries sampled whereas diclofenac 246 
was only detected in two of the other estuaries, the Cromarty and Thames (Figure 4). The 247 
Thames and Humber were the only estuaries to contain all of the compounds. The Humber 248 
had the overall highest concentration of pharmaceuticals and only the Cromarty and Tay had 249 
a total concentration of pharmaceuticals over 200 ng l-1 (Figure 4). 250 
 251 
 252 
Figure 4 Concentrations of citalopram, diclofenac, ibuprofen, paracetamol and trimethoprim across 253 
eleven estuaries in the UK. Concentrations have been corrected for recovery (Table 3). 254 
Concentrations reported for the Humber are maximum concentrations measured in August, when the 255 
wider UK survey was undertaken.  256 
 257 
4. Discussion 258 
Most monitoring studies to date have been carried out in freshwater systems as it was 259 
originally thought that estuaries and coastal waters would dilute compounds so that they 260 
would be undetectable (Fabbri and Franzellitti 2016). Despite this hypothesis, 261 
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pharmaceutical contamination was found to be widespread and all of the estuaries 262 
monitored in the current study contained at least three of the target analytes at levels of a 263 
similar magnitude to those found in the freshwater environment, and higher than those 264 
measured in many other estuaries (Hughes et al. 2013; Table 1). The levels of 265 
pharmaceuticals detected in this study contribute to the overall picture on pharmaceutical 266 
pollution and add to the growing evidence of this global issue (aus der Beek et al. 2016). Our 267 
work indicates that the limited monitoring carried out to date may not have captured peak 268 
concentrations that occur in these environments and clearly highlights that further work is 269 
needed. 270 
Ibuprofen was detected at the highest concentrations and in all of the estuaries sampled, 271 
with its occurrence not only exceeding levels detected in other estuaries (Table 1) but also 272 
those seen in river water both in the UK (Barbara Kasprzyk-Hordern et al. 2008; Kay et al. 273 
2017; Burns et al. 2017, 2018) and globally (Hughes et al. 2013). Ibuprofen has only been 274 
measured in seven estuaries previously, with maximum concentrations all under 1000 ng l-1 275 
(Table 1). Further monitoring studies should include ibuprofen as a priority to determine if 276 
high concentrations seen in the UK are similar to those elsewhere.  277 
Concentrations of paracetamol, diclofenac and trimethoprim were similar to those seen in 278 
other global estuaries, with mean concentrations less than 100 ng l-1 (Table 1). Whilst 279 
maximum concentrations of paracetamol were similar to those detected in rivers (Barbara 280 
Kasprzyk-Hordern et al. 2008; Burns et al. 2017), concentrations of diclofenac and 281 
trimethoprim were considerably lower (Hughes et al. 2013; Nakada et al. 2017). In the 282 
present study, water samples were collected at high tide, when concentrations would be 283 
expected to be lowest, so it is possible that these levels could be higher at other points in the 284 
tidal cycle (Yang et al. 2016). This is the first study to measure the occurrence of citalopram 285 
although concentrations were low and did not exceed 50 ng l-1, in agreement with previous 286 
studies which have monitored citalopram in rivers (Hughes et al. 2013). Nevertheless, 287 
PNECs for citalopram are below this level (Minguez et al. 2016).  288 
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Whilst widespread occurrence of pharmaceuticals was seen in the UK patterns in their 289 
spatial and temporal distributions within and between estuaries were observed.  290 
 291 
4.1 Humber Estuary 292 
4.1.1 Spatial Variation 293 
It is generally expected that pharmaceutical concentrations will decrease downstream due to 294 
physical processes in an estuary leading to their breakdown and removal (Daughton 2016). 295 
The spatial pattern of pharmaceutical occurrence in the Humber Estuary followed this 296 
pattern to a degree; peak concentrations were found in the middle of the estuary, particularly 297 
at R1, where samples were collected next to an outlet from a wastewater treatment plant 298 
(WWTP), indicating that WWTPs could be a significant source of pharmaceuticals in the 299 
Humber Estuary. Input from WWTPs has been attributed as the largest source of 300 
pharmaceutical pollution in the aquatic environment (Caldwell 2016). In some cases 301 
maximum concentrations were detected outside of this site; in April and June maximum 302 
concentrations for paracetamol and ibuprofen occurred at sites R2-4. It is difficult to 303 
determine what caused these peaks although these sites are within 6km from R1, so it is 304 
possible that the large increases seen at these sites are still due to input at R1, and 305 
fluctuations between these sites are the result of sampling timing (Ort et al. 2010). The site 306 
(R4) which showed the highest levels (6.2 µg l-1) of ibuprofen was also 7km upstream from 307 
the confluence of the River Hull. Transport of pharmaceuticals from this tributary upstream 308 
during high tide could also account for the increases seen. The River Trent, located near the 309 
confluence with the Ouse (Figure 1), could also account for the addition of further 310 
pharmaceuticals. Inputs of pharmaceuticals in other studies have also been attributed to 311 
other sources such as improper disposal, leaching from landfills or through veterinary usage 312 
and subsequent runoff of these compounds into the aquatic environment, which could also 313 
account for these differences  (Bound and Voulvoulis 2005; Ebele et al. 2017). 314 
 19 
 
Dilution plays a key role in the fate of pharmaceuticals in the aquatic environment and the 315 
decrease in concentrations after R1 is presumably caused by dilution away from the input 316 
source (Baker and Kasprzyk-Hordern 2013). Decline of pharmaceutical concentrations 317 
downstream in the estuary was observed to a greater extent for some compounds and, 318 
therefore, is unlikely to be entirely due to dilution. Degradation has been found to be a 319 
significant factor affecting the fate of pharmaceuticals and could account for these 320 
differences (Caracciolo et al. 2015).  Citalopram experienced the lowest decrease in 321 
concentration downstream and was typically found at the same concentration or higher at A5 322 
compared to A1, which could be explained by the low degradation which has been observed 323 
in other studies  (Metcalfe et al. 2010; Styrishave et al. 2011). Ibuprofen, paracetamol and 324 
trimethoprim also showed little decline in concentration beyond initial dilution after R1, which 325 
is consistent with what has been seen at other sites. These compounds have been found up 326 
to 10 km downstream from a WWTP (Bendz et al. 2005, Kay et al. 2017, Burns et al. 2018), 327 
and trimethoprim has even been found 200 km downstream from a WWTP (Tamtam et al. 328 
2008). Further WWTPs are located within the estuary (European Environment Agency, 329 
2019) which could also account for this lack in decline. Diclofenac on the other hand, was 330 
not detected at A3 or A5 during any of the sampling periods, but was found at A4.  The 331 
downstream decline of diclofenac has been found to be variable, with some studies finding it 332 
to be more persistent than others (Bendz et al. 2005; Wilkinson et al. 2017). Removal of 333 
compounds through degradation and sorption to sediment has been found to be highly 334 
dependent on environmental conditions and sediment type.  335 
4.2.1 Temporal Variation 336 
Seasonal differences of pharmaceuticals have been observed in a number of studies and 337 
these are often attributed to changes in usage and local environmental conditions (Golovko 338 
et al. 2014b; Moreno-González et al. 2014). Trimethoprim was the only compound to show 339 
significant temporal differences in concentrations (at sites R1-R4), with average winter 340 
concentrations more than double that of those found during the summer months. Previous 341 
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studies have explained the occurrence of antibiotics in winter due to their higher usage in 342 
those months to treat seasonal infections (Verlicchi and Zambello 2016).  The temporal 343 
differences seen in the occurrence of trimethoprim in the Humber Estuary appeared to follow 344 
this pattern as prescriptions were highest in October 2016 to March 2017 and lowest in 345 
August 2017 (supplementary material S4). Trimethoprim has been observed to have higher 346 
winter concentrations in some studies (Golovko et al. 2014b) but not in others (Burns et al. 347 
2018). Burns et al. (2018) found higher levels of trimethoprim during spring in the Ouse 348 
(upstream from A1), which was attributed to hydrological differences seen between the 349 
seasons sampled. As a result, it is likely that the temporal differences in trimethoprim are the 350 
result of different site specific conditions or daily variations. Temporal variations in other 351 
studies have also been explained by lower temperatures leading to lower degradation 352 
(Golovko et al. 2014a), however, input at R1 was highest in April. The other target 353 
compounds have exhibited seasonal patterns in other studies but did not in the Humber. 354 
Paracetamol, for instance, has been detected at high concentrations in spring in some rivers 355 
but winter in others, whilst other studies found no temporal variations (Paíga et al. 2016; Ma 356 
et al. 2017; Burns et al. 2018).  357 
Temporal variations in the downstream pattern of pharmaceuticals were also observed, with 358 
the greatest variation seen at the sites furthest downstream (A3-A5). Pharmaceuticals were 359 
mostly absent from these sites in October, with the exception of ibuprofen, where 360 
concentrations were reduced. Sampling at high tide could account for the absence of these 361 
pharmaceuticals downstream as the result of increased dilution or transport of contaminants 362 
upstream (Munro et al. 2019). Pharmaceutical concentrations often fluctuate diurnally as the 363 
result of the timing of effluent discharges from WWTPs and combined sewer overflows 364 
(CSOs), as well as variations in wastewater quantities as the result of consumption patterns 365 
(Xu et al. 2007). To an extent, there was a pattern in the presence of compounds at R1 366 
consistent with those seen downstream in the estuary, so it is possible that the temporal 367 
variations could be the result of these daily variations, instead of conditions seen seasonally. 368 
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The concentration of pharmaceuticals at R1 were lowest in October and the low input could, 369 
in part, account for the absence of compounds seen at sites furthest downstream (A3-A5).  370 
Likewise, concentrations for the majority of compounds were highest at R1 during February 371 
where concentrations were highest at sites furthest downstream (A3-A5). This is further 372 
evidence that there is a difference in input from WWTPs. R1 is not the only site at which 373 
wastewater is discharged but if these other sites exhibit the same temporal variations then it 374 
could explain the differences observed in concentrations at A3-A5. WWTP removal has been 375 
found to be less efficient during the winter time due to lower temperatures and decreased 376 
biodegradation, leading to higher concentrations in effluent (Vieno et al. 2005). At R1, 377 
concentrations for all compounds were lowest in August when temperatures were warmest 378 
(supplementary material S1). 379 
 380 
4.3 UK Estuaries   381 
The Humber Estuary was shown to represent a worst case scenario in terms of 382 
pharmaceutical pollution, with all five pharmaceuticals present at relatively high 383 
concentrations. Of the estuaries sampled, it was the second highest impacted by WWTPs, 384 
with a PE of approximately 13.7 million people. The Thames, which was the most impacted, 385 
was the only other estuary to contain all five compounds. A higher presence of  386 
pharmaceuticals is frequently seen in large urban areas due to their increased usage (Hong 387 
et al. 2018). With the exception of both the Humber and the Thames estuaries, there was no 388 
apparent relationship between the number of WWTP and concentrations (Table 2). The 389 
Cromarty Firth, which was the receiving water of only 3 WWTPs (15,600 PE), exhibited 390 
similar levels of pharmaceuticals to the Humber. This could be explained by differences in 391 
WWTP efficiency, as technology used in WWTPs can greatly affect the removal of 392 
pharmaceuticals. For example, ibuprofen removal has been reported to be between 7% and 393 
99% at different WWTPs (Radjenovic et al. 2007; Jelic et al. 2015). It is possible that the 394 
removal efficiency of WWTPs could differ between areas, with rural areas being less efficient 395 
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as they are serving smaller populations. Rural areas are more likely to have a higher 396 
occurrence of septic tanks, which could contribute to the elevated levels seen in the 397 
Cromarty (Hanamoto et al. 2018). Whilst the Humber experienced the lowest concentration 398 
in August, it is possible that seasonal variations in population in areas like the Scottish 399 
Highlands (a tourist destination), where the Cromarty is located, could be responsible for 400 
these higher concentrations, increasing pressure on WWTPs. Pharmaceuticals in a 401 
Portuguese river have previously shown higher concentrations which was thought to be the 402 
result of increased summer populations (Rocha et al. 2014).  403 
The presence of pharmaceuticals is greatly influenced by environmental conditions and 404 
proximity of the sampling site to input sources, possibly accounting for some of the apparent 405 
differences in concentrations observed between estuaries. Water samples from different 406 
locations in the estuary were mixed together and a subsample was taken to obtain a 407 
snapshot of the presence of pharmaceuticals, and it is likely that these concentrations will 408 
vary depending on these factors. This could possibly explain the absence of diclofenac, 409 
which in the Humber study was frequently undetected in sites downstream in the estuary. 410 
Citalopram also had a low detection (50%) in estuaries, however, it was detected in 411 
estuaries which have the highest PE.  412 
There are also likely to be more complex interactions in play which further affect the 413 
occurrence of pharmaceuticals in estuaries and which can help to explain the spatial 414 
differences seen. Differences in site specific conditions such as salinity profiles and 415 
hydrology can affect sorption processes, degradation and dilution. Undoubtedly, these 416 
processes, in conjunction with daily variations in rainfall and temperature, are likely to be 417 
responsible for differences in concentrations in estuaries between sampling periods, yet it is 418 
still clear that pharmaceutical pollution is a ubiquitous problem in estuaries (Tamtam et al. 419 
2008). 420 
Ibuprofen, paracetamol, diclofenac and trimethoprim were previously monitored in the 421 
Mersey, Thames, Tees and Tyne estuaries (as well as Belfast Lough) in 2002 (Thomas and 422 
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Hilton, 2004).  It was also found that ibuprofen was present at the highest concentrations. 423 
Paracetamol, however, was not detected in any of the estuaries sampled in 2002, which 424 
indicates that the occurrence of this compound could be rising. A rise in pharmaceuticals 425 
would be consistent with what has been found in other areas. For example, analysis of 426 
sediment cores in Jamaica showed an overall rise in pharmaceutical concentrations over 427 
time, with these concentrations doubling over the last decade (Lara-Martin et al. 2015). This 428 
highlights the importance of establishing baseline measurements of pharmaceuticals, in 429 
order to determine areas most at risk and therefore requiring continued monitoring. The 430 
Humber Estuary likely poses the greatest risk, particularly due to the high level 431 
concentrations of ibuprofen. Other large urban estuaries (such as the Thames and Severn) 432 
may also warrant a further detailed study. However, as seen with the Cromarty, focus on 433 
monitoring should be extended to rural areas as well.  434 
 435 
5. Conclusion 436 
All five target analytes, ibuprofen, paracetamol, diclofenac, trimethoprim and citalopram, 437 
were detected in twelve estuaries in the UK. Diclofenac is a compound that has been 438 
highlighted by EU legislation as a potential concern yet paracetamol and ibuprofen were 439 
consistently detected at higher concentrations and at levels which could be toxic to aquatic 440 
organisms (Vestel et al. 2016). In particular, the concentrations of ibuprofen measured 441 
indicate that the limited monitoring of pharmaceuticals in estuaries around the globe to date 442 
has not accurately quantified peak concentrations. Whilst trimethoprim was detected in every 443 
sample it was only present at concentrations in the low ng l-1 range and although citalopram 444 
was present at lowest concentrations it showed the least change in concentration 445 
downstream. A more intensive monitoring regime of the Humber Estuary showed that 446 
pharmaceutical input from WWTPs is a significant source and could explain the overall 447 
higher concentrations of pharmaceuticals in large urban estuaries. Despite this, a rural 448 
estuary had the highest concentration of ibuprofen which may be due to lower removal at 449 
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smaller rural sewage works. More detailed studies need to be undertaken in order to 450 
understand the complex interactions taking place in estuaries which could affect the fate of 451 
pharmaceuticals. 452 
Whilst there was little significant variation of pharmaceutical concentrations between 453 
sampling periods in the Humber Estuary, August typically had the lowest input from WWTPs 454 
and overall lowest concentrations, which is when samples were taken from estuaries 455 
throughout the UK. Consequently, it could be expected that pharmaceutical concentrations 456 
may exceed those measured. Additionally, samples were taken on a high tide when it would 457 
be expected that concentrations are lowest due to dilution. This study provides an important 458 
baseline of pharmaceutical measurements in the UK and highlights ibuprofen as a 459 
compound which may warrant further assessment. This work provides further evidence to 460 
the growing problem of pharmaceutical pollution, highlighting that it is not only an urban and 461 
localised issue. 462 
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